Destiny Capital Corp CO trimmed its holdings in DocuSign, Inc. (NASDAQ:DOCU – Free Report) by 4.7% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 26,903 shares of the company’s stock after selling 1,340 shares during the quarter. DocuSign comprises 1.0% of Destiny Capital Corp CO’s portfolio, making the stock its 16th biggest holding. Destiny Capital Corp CO’s holdings in DocuSign were worth $1,670,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Oppenheimer Asset Management Inc. bought a new position in DocuSign in the first quarter valued at about $251,000. Russell Investments Group Ltd. boosted its stake in shares of DocuSign by 24.8% in the 1st quarter. Russell Investments Group Ltd. now owns 224,433 shares of the company’s stock valued at $13,360,000 after purchasing an additional 44,597 shares during the last quarter. Avantax Advisory Services Inc. grew its position in shares of DocuSign by 7.1% during the 1st quarter. Avantax Advisory Services Inc. now owns 16,173 shares of the company’s stock worth $963,000 after buying an additional 1,077 shares during the period. BNP PARIBAS ASSET MANAGEMENT Holding S.A. raised its stake in shares of DocuSign by 336.7% during the first quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 57,812 shares of the company’s stock worth $3,443,000 after buying an additional 44,573 shares during the last quarter. Finally, Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in DocuSign by 22.8% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 103,048 shares of the company’s stock valued at $6,137,000 after buying an additional 19,149 shares during the period. Institutional investors and hedge funds own 77.64% of the company’s stock.
DocuSign Stock Performance
Shares of DOCU stock opened at $79.11 on Friday. DocuSign, Inc. has a 52-week low of $42.12 and a 52-week high of $83.68. The stock has a market cap of $16.06 billion, a price-to-earnings ratio of 16.69, a PEG ratio of 8.66 and a beta of 0.90. The firm’s 50-day moving average is $67.05 and its 200-day moving average is $59.48.
Insider Buying and Selling at DocuSign
In other DocuSign news, Director Teresa Briggs sold 534 shares of the company’s stock in a transaction on Monday, September 16th. The stock was sold at an average price of $56.56, for a total value of $30,203.04. Following the transaction, the director now directly owns 7,202 shares of the company’s stock, valued at $407,345.12. This represents a 6.90 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Allan C. Thygesen sold 7,725 shares of the stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $59.09, for a total value of $456,470.25. Following the transaction, the chief executive officer now owns 102,193 shares in the company, valued at $6,038,584.37. The trade was a 7.03 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 69,558 shares of company stock valued at $4,272,768 in the last quarter. 1.66% of the stock is currently owned by insiders.
Analyst Ratings Changes
A number of analysts have commented on the stock. Robert W. Baird lifted their target price on shares of DocuSign from $55.00 to $59.00 and gave the stock a “neutral” rating in a report on Friday, September 6th. Royal Bank of Canada upped their price objective on DocuSign from $52.00 to $57.00 and gave the company a “sector perform” rating in a report on Friday, September 6th. Bank of America raised their target price on DocuSign from $60.00 to $68.00 and gave the stock a “neutral” rating in a report on Friday, September 6th. Citigroup boosted their target price on DocuSign from $86.00 to $87.00 and gave the stock a “buy” rating in a research report on Friday, September 6th. Finally, Wells Fargo & Company increased their price target on shares of DocuSign from $48.00 to $50.00 and gave the company an “underweight” rating in a research report on Friday, September 6th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $63.40.
View Our Latest Report on DOCU
DocuSign Company Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Read More
- Five stocks we like better than DocuSign
- Business Services Stocks Investing
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- Investing in Travel Stocks Benefits
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- The Significance of Brokerage Rankings in Stock Selection
- Time to Load Up on Home Builders?
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocuSign, Inc. (NASDAQ:DOCU – Free Report).
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.